Wang Yongwei, Du Yali, Liu Gang, Guo Shanshan, Hou Bo, Jiang Xianyong, Han Bing, Chang Yanzhong, Nie Guangjun
Laboratory of Molecular Iron Metabolism, College of Life Science, Hebei Normal University, Shijiazhuang, 050024, Hebei, China.
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, No. 11 Beiyitiao, Zhongguancun, Beijing, 100190, China.
Int J Hematol. 2017 Apr;105(4):521-525. doi: 10.1007/s12185-016-2150-8. Epub 2016 Nov 28.
Hereditary hemochromatosis (HH) is a group of inherited iron-overload disorders associated with pathogenic defects in the genes encoding hemochromatosis (HFE), hemojuvelin (HJV/HFE2), hepcidin (HAMP), transferrin receptor 2 (TfR2), and ferroportin (FPN1/SLC40A1) proteins, and the clinical features are well described. However, there have been only a few detailed reports of HH in Chinese populations. Thus, there is insufficient patient information for population-based analyses in Chinese populations or comparative studies among different ethical groups. In the current work, we describe eight Chinese cases of hereditary hemochromatosis. Gene sequencing results revealed eight mutations (five novel mutations) in HFE, HFE2, TfR2, and SLC40A1 genes in these Chinese HH patients. In addition, we used Polymorphism Phenotyping v2 (Polyphen), Sorting Intolerant From Tolerant (SIFT), and a sequence alignment program to predict the molecular consequences of missense mutations.
遗传性血色素沉着症(HH)是一组遗传性铁过载疾病,与编码血色素沉着症(HFE)、血色素沉着蛋白(HJV/HFE2)、铁调素(HAMP)、转铁蛋白受体2(TfR2)和铁转运蛋白(FPN1/SLC40A1)的基因中的致病缺陷相关,其临床特征已有详细描述。然而,关于中国人群中HH的详细报道仅有少数几例。因此,在中国人群中进行基于人群的分析或不同种族群体间的比较研究时,患者信息不足。在当前研究中,我们描述了8例中国遗传性血色素沉着症病例。基因测序结果显示,这些中国HH患者的HFE、HFE2、TfR2和SLC40A1基因存在8种突变(5种新突变)。此外,我们使用多态性表型分析v2(Polyphen)、耐受与不耐受排序(SIFT)和序列比对程序来预测错义突变的分子后果。